Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts
- 31 December 1995
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 3 (4), 342-351
- https://doi.org/10.1016/0966-3274(95)80021-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- TREATMENT WITH RAPAMYCIN AND MYCOPHENOLIC ACID REDUCES ARTERIAL INTIMAL THICKENING PRODUCED BY MECHANICAL INJURY AND ALLOWS ENDOTHELIAL REPLACEMENTTransplantation, 1995
- Mechanism of action of cyclosporine: a new hypothesis implicating transforming growth factor-βTransplantation Reviews, 1995
- Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate MofetilImmunological Reviews, 1993
- Pathogenesis and Treatment Perspectives of Chronic Graft Rejection (CVR)Immunological Reviews, 1993
- Mycophenolate mofetil (RS-61443): Mechanisms of action and effects in transplantationTransplantation Reviews, 1993
- SUPPRESSION OF SYNTHESIS OF NATURAL ANTIBODIES BY MYCOPHENOLATE MOFETIL (RS-61443)Transplantation, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- RS-61443—A PHASE I CLINICAL TRIAL AND PILOT RESCUE STUDY 1Transplantation, 1992
- Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Phenotype modulation in primary cultures of arterial smooth muscle cellsDifferentiation, 1984